Anti-glatiramer acetate antibody levels in treated multiple sclerosis patients

被引：0
|
作者：
Oger, J [1 ]
Gibb, E [1 ]
Basile, E [1 ]
Aziz, T [1 ]
机构：
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷 / 01期
关键词：
enzyme linked immunosorbent assay; ELISA; glatiramer acetate (GA); immunoglobulin G; IgG; optical density; OD; peripheral blood mononuclear cells; PBMC; pokeweed mitogen; PWM;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [21] Sustained immunological effects of Glatiramer acetate in patients with multiple sclerosis treated for over 6 years
    Chen, M
    Conway, K
    Johnson, KP
    Martin, R
    Dhib-Jalbut, S
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 201 (1-2) : 71 - 77
  • [22] MicroRNAs Associated with Disability Progression and Clinical Activity in Multiple Sclerosis Patients Treated with Glatiramer Acetate
    Casanova, Ignacio
    Dominguez-Mozo, Maria I.
    De Torres, Laura
    Aladro-Benito, Yolanda
    Garcia-Martinez, Angel
    Gomez, Patricia
    Abellan, Sara
    De Antonio, Esther
    Alvarez-Lafuente, Roberto
    BIOMEDICINES, 2023, 11 (10)
  • [23] Persistence and adherence to interferon and glatiramer acetate in patients with multiple sclerosis
    Bartolome-Garcia, Emma
    Usarralde-Perez, Angela
    Sanmartin-Fenollera, Patricia
    Perez-Encinas, Monserrat
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2019, 26 (01) : 23 - 28
  • [24] Effect of glatiramer acetate on diffusion imaging in patients with multiple sclerosis
    Zivadinov, R.
    Hussein, S.
    Abdelrahman, N.
    Cookfair, D. L.
    Meyer, M.
    Garg, A.
    Cox, J. L.
    Dwyer, M. G.
    Weinstock-Guttman, B.
    MULTIPLE SCLEROSIS, 2006, 12 : S99 - S99
  • [25] Lymphadenopathy in patients with multiple sclerosis undergoing treatment with glatiramer acetate
    Windhagen, A
    Maniak, S
    Marckmann, S
    Wilkening, A
    Lindert, RB
    Heidenreich, F
    Blasczyk, R
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (03): : 415 - 416
  • [26] Metabolic response to glatiramer acetate therapy in multiple sclerosis patients
    De Riccardis, Lidia
    Ferramosca, Alessandra
    Danieli, Antonio
    Trianni, Giorgio
    Zara, Vincenzo
    De Robertis, Francesca
    Maffia, Michele
    BBA CLINICAL, 2016, 6 : 131 - 137
  • [27] Glatiramer acetate: Mechanisms of action in multiple sclerosis
    Ziemssen, Tjalf
    Schrempf, Wiebke
    NEUROBIOLOGY OF MULTIPLE SCLEROSIS, 2007, 79 : 537 - 570
  • [28] Is glatiramer acetate better for pregnancy in multiple sclerosis?
    Kasatkin, D. S.
    Vinogradova, T. V.
    Shitova, A. S.
    Spirin, N. N.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E307 - E308
  • [29] Glatiramer acetate (Copaxone®) therapy for multiple sclerosis
    Dhib-Jalbut, S
    PHARMACOLOGY & THERAPEUTICS, 2003, 98 (02) : 245 - 255
  • [30] Characterization of T cell lines derived from glatiramer-acetate-treated multiple sclerosis patients
    Qin, YF
    Zhang, DQ
    Prat, A
    Pouly, S
    Antel, J
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 108 (1-2) : 201 - 206
12345